Disclosure: This post contains affiliate links. If you purchase through them, we may earn a commission at no extra cost to you. We only recommend products that meet our evidence standard.
Key Takeaways
- Wegovy is FDA-approved. Compounded semaglutide isn’t, which means the FDA doesn’t review it for safety, effectiveness or quality before it’s sold.
- The FDA declared the semaglutide shortage resolved on February 21, 2025. Compounding copies of Wegovy since then is allowed only in narrow cases.
- The price gap depends on the form. GobyMeds’ three-month bundle for first-time patients works out to $99 a month, while NovoCare sells Wegovy pens self-pay at $349 a month (new patients pay $199 for the first two fills of the lowest doses through December 31, 2026) and Wegovy tablets from $149 to $299.
- Before ordering either one, find out which pharmacy fills it, check its license yourself, and know the FDA’s rules for vials and shipping.
Compounded semaglutide vs Wegovy is a question about paperwork. Same drug name, very different approval status, oversight and price.
Here’s what the FDA says, with dates, plus what researchers found.
What Does Compounded Semaglutide Mean?
It means a pharmacy mixed the medication itself instead of buying it from the manufacturer. The FDA defines compounding as a licensed pharmacist or physician combining, mixing or altering ingredients to create a medication tailored to an individual patient.
The FDA says compounded drugs should only be used when a patient’s medical needs can’t be met by an approved drug. A compounded drug is also not a generic. A generic is approved and shown to perform like the brand. A compounded drug is not approved at all.
Wegovy is made by Novo Nordisk and comes as a pre-filled injection or a daily tablet. The FDA says compounded GLP-1s may be dispensed in multi-dose vials that you draw up yourself.
That matters. With a pen or a tablet, the dose is set for you. With a vial, you’re measuring it.
Is Compounded Semaglutide FDA Approved?
No. In the FDA’s own words, compounded drugs are not FDA approved, and the agency does not review them for safety, effectiveness or quality before they’re marketed.
That doesn’t make every compounded product bad. It means the FDA didn’t review it before sale the way it reviewed Wegovy.
The FDA’s page on unapproved GLP-1 drugs, current as of October 1, 2026, lists 990 adverse event reports involving compounded semaglutide and more than 730 for compounded tirzepatide, counted as of May 31, 2026. It says the real number is probably higher, because federal law doesn’t require state-licensed pharmacies that aren’t outsourcing facilities to report adverse events to the FDA.
The FDA says some reports may relate to dosing errors, where patients measured the wrong amount or a health care professional miscalculated the dose.
Is Compounded Semaglutide Being Banned?
Not banned, but squeezed hard. During the shortage, pharmacies were allowed to make copies of the brand-name drug. That window has closed.
Here’s the timeline from the FDA:
- February 21, 2025: the FDA determined the semaglutide injection shortage was resolved.
- April 24, 2025: a federal court denied the request to block the FDA’s action, and the grace period ended for state-licensed 503A pharmacies.
- May 22, 2025: the grace period ended for 503B outsourcing facilities.
- April 30, 2026: the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the list of bulk ingredients 503B facilities may compound with. Comments closed June 29, 2026. No final decision showed up on the FDA pages I checked.
So how is compounded semaglutide still sold? A 503A pharmacy can’t regularly make essentially a copy of an approved drug, meaning the same active ingredient in a similar strength given the same way. The exception is when a prescriber documents that the compounded version makes a significant difference for an identified individual patient. The FDA also says that for now it does not intend to act against a compounder that fills four or fewer prescriptions of an essentially-copy drug in a calendar month.
What’s the Difference Between a 503A and a 503B Pharmacy?
A 503A pharmacy compounds against a valid prescription for an individual patient. It’s state-licensed, and state boards of pharmacy have primary responsibility for overseeing it.
A 503B outsourcing facility registers with the FDA, is inspected by the FDA on a risk-based schedule and has to meet Current Good Manufacturing Practice rules. The FDA says 503A pharmacies aren’t held to those manufacturing requirements.
Neither one makes the product FDA-approved. A 503B facility just sits under more federal oversight, and the FDA publishes its registered facilities. Ask which kind fills your order. GobyMeds says on its own site that your prescription goes to a 503A or 503B pharmacy partner licensed in your state.
Is Compounded Semaglutide as Effective as Wegovy?
I found no head-to-head trial comparing compounded and brand-name semaglutide, and compounded versions don’t go through FDA review. Wegovy’s results come from Wegovy. They don’t automatically transfer to a vial made elsewhere.
Here’s what the approved drug did. In STEP 1, published in the New England Journal of Medicine, 1,961 adults with obesity or overweight took semaglutide 2.4 mg or a placebo for 68 weeks, alongside a lifestyle program. Average body weight fell 14.9% on semaglutide and 2.4% on placebo. That’s a trial result for the approved product, not a forecast for you and not a claim about any compounded product.
There’s one more thing to watch. Compounded GLP-1s are not FDA-approved, and the FDA says salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from the ones in the approved drugs. The agency says it isn’t aware of any lawful basis for using them in compounding. Ask what’s in yours.
What Does Independent Research Say About Compounded GLP-1 Quality?
Peer-reviewed testing is thin, and the lab studies I found came from the companies that make the brand-name drugs.
The non-drugmaker study I found is a secret shopper project in JAMA Health Forum. University of Colorado researchers looked at 75 weight-loss clinics and medical spas in West Virginia and Oklahoma between August and October 2025. Of those, 42 (56.0%) reported offering GLP-1 products combined with B vitamins. The researchers identified 23 supplying compounding facilities, and 4 of 21 (19.0%) weren’t licensed for sterile compounding. Three of 22 (13.6%) had faced state disciplinary action since 2023.
That’s two states at one point in time, not a national average. Two 2026 lab studies also looked at quality. Novo Nordisk employees and shareholders found that compounded semaglutide samples had different impurity profiles from the original. Eli Lilly authors reported a widespread impurity in compounded tirzepatide and B12 products, with unknown clinical effects. Treat those as signals, not proof.
How Long Can You Use a Compounded Semaglutide Vial?
The FDA recommends using a multi-dose vial within 28 days of first use, because contamination risk rises after that. Throw it out at 28 days even if medication is left, and even if the compounder says it lasts longer. Use a new sterile needle and syringe for every dose.
What Should I Do If Compounded Semaglutide Arrives Warm?
Don’t use it. The FDA says injectable GLP-1 drugs need refrigeration as stated in their package inserts. It has received complaints about compounded products arriving warm or with too few ice packs, and it recommends not using any that does, because heat can affect quality.
Our GLP-1 guide for men over 50 covers what to expect once you’ve started.
What Are the Red Flags in a Telehealth GLP-1 Offer?
The FDA publishes its own list of warning signs. Be wary of a company that:
- says its compounded drug is the same as an FDA-approved one
- offers medicine at deep discounts or prices that seem too good to be true
- doesn’t require a screening and prescription from a licensed doctor
- has no licensed doctor to answer questions after the medicine arrives
The FDA also warns of fraudulent products whose labels name pharmacies that don’t exist, and of GLP-1 drugs labeled “for research purposes” or “not for human consumption” that were sold for human use with dosing instructions.
How Much Is Compounded Semaglutide vs Wegovy?
As of October 2026, first-time patients can start GobyMeds with a three-month bundle: $299 for compounded semaglutide or $399 for compounded tirzepatide, which works out to $99 and $133 a month. A single month is listed from $169 for semaglutide and from $299 for tirzepatide, and higher doses cost more. Brand-name Zepbound is listed at $1,399 a month and Wegovy at $1,695 a month. Prescriptions are final sale.
NovoCare sells Wegovy pens self-pay at $349 a month for the 1 mg, 1.7 mg and 2.4 mg doses and $399 for the 7.2 mg HD dose. New patients pay $199 a month for their first two fills of the two lowest doses, through December 31, 2026. Wegovy tablets run from $149 to $299 a month.
Against the pen, GobyMeds’ starter bundle runs about $250 a month less. Against the tablet the gap is much smaller, roughly $50 to $200.
One note for men getting close to 65: NovoCare’s $25 savings offer excludes government beneficiaries, and self-pay spending by government-insured patients can’t count toward Medicare Part D out-of-pocket totals. If you’re on Medicare, confirm your price first.
How Do I Check a Compounding Pharmacy’s License?
Go to your state board of pharmacy’s license lookup and search the pharmacy’s name. The FDA’s BeSafeRx page links to each state’s database and says that if the pharmacy isn’t listed, don’t use it.
If it is listed, the FDA says to confirm it requires a prescription, has a U.S. address and phone number, and has a licensed pharmacist who answers questions. For a 503B facility, check the FDA’s registered outsourcing facilities list too.
What Should a Man Over 50 Ask Before Ordering Compounded Semaglutide?
Ask these before you pay, not after the vial shows up:
- Which pharmacy fills my prescription, and is it 503A or 503B?
- Is it semaglutide itself, or a salt form like semaglutide sodium or acetate?
- Does it come in a vial or a pen, and exactly how do I measure each dose?
- What’s documented as the clinical reason I’m getting a compounded version instead of Wegovy?
- Who reviews my current medications, and who do I contact if a dose isn’t working?
If you take blood pressure, cholesterol or diabetes medication, that list matters more. Dose decisions belong with the prescriber who has your full history.
A good provider answers all of them without getting defensive. If you want to see how one telehealth service handles this, GobyMeds lists its compounded and brand-name options here, and our GobyMeds review covers its pricing and pharmacy questions in more detail. It’s worth putting ShedRX next to it before you commit.
Compounded isn’t the villain and brand-name isn’t magic. One costs more and is FDA-approved. The other costs less and isn’t reviewed by the FDA before sale, so the questions in this post matter more.
Frequently Asked Questions
Can a compounding pharmacy still make semaglutide?
Yes, in limited cases. A 503A pharmacy can compound it with a prescription, but generally not as a regular copy of Wegovy unless the prescriber documents a significant difference for that patient. The FDA said in April 2026 that semaglutide is on neither the 503B bulks list nor the drug shortage list, which limits what outsourcing facilities can make.
Does compounded semaglutide need to be refrigerated?
The FDA says injectable GLP-1 drugs require refrigeration as indicated in their package inserts. GobyMeds’ own FAQ says to store its compounded GLP-1 medications between 36 and 46 degrees Fahrenheit and never freeze them.
Can you use an HSA for compounded semaglutide?
GobyMeds says it accepts HSA and FSA cards and doesn’t bill insurance. Whether a purchase counts as an eligible expense is a question for your plan administrator.
Can compounding pharmacies still make tirzepatide?
The same rules apply. The FDA declared the tirzepatide shortage resolved on December 19, 2024, and compounded tirzepatide is not FDA-approved either. The April 2026 proposal would exclude it from the 503B bulks list too.
What is compounded semaglutide mixed with?
B vitamins are a common add-in. The FDA says it may treat a semaglutide and vitamin B12 product as essentially a copy of an approved drug when the route and strengths match, so a vitamin doesn’t automatically count as a meaningful difference.
Related Reading
- GLP-1 side effects for men over 50: whichever version you pick, this is what the first few weeks can actually feel like.
- GobyMeds semaglutide vs tirzepatide: once you’ve sorted compounded versus brand-name, this is the next decision on the list.
- GobyMeds vs ShedRX: if you’re comparing telehealth providers, this lines up their listed prices and terms side by side.